Search Results - "Boiko, Julie R"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Hematopoiesis sculpted by pathogens: Toll-like receptors and inflammatory mediators directly activate stem cells by Boiko, Julie R., Borghesi, Lisa

    Published in Cytokine (Philadelphia, Pa.) (01-01-2012)
    “…► Hematopoietic stem cells (HSCs) functionally respond to Toll-like receptor (TLR) ligation. ► TLR ligation of HSCs alters self-renewal and differentiation…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Care Coordination in a SARS-CoV-2-infected Child With Newly Diagnosed Medulloblastoma and Fanconi Anemia by Field, Mary T., Chapple, Alayne, Hoeppner, Corrine, Boiko, Julie R., Tellinghuisen, Amy, Joshi, Sarita, Vitanza, Nicholas A.

    Published in Journal of pediatric hematology/oncology (01-10-2021)
    “…COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is responsible for a global pandemic that can cause severe infections in…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Portomesenteric Venous Thrombosis As First Presentation of Thrombophilic Disorders in Adolescents by Boiko, Julie R., Cooper, James D.

    Published in Blood (06-12-2014)
    “…Introduction Portomesenteric venous thrombosis is rare in children and adolescents. Rapid recognition of this uncommon phenomenon is essential to prevent…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Characterization of Regulatory T Cell Reconstitution after Allogeneic Hematopoietic Cell Transplantation: Expansion Potential at 100 Days Predicts De Novo Graft-Versus-Host Disease By Six Months Post-Transplantation by Boiko, Julie R., Im, Annie, Chen, Xiaohua, Hill, Memphis J, Szabolcs, Paul

    Published in Blood (03-12-2015)
    “…Introduction Regulatory T cells (CD4+CD25high CD127low Foxp3+) (Tregs) are of increasing interest in the context of allogeneic hematopoietic cell…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Decreasing chronic graft-versus-host disease rates in all populations by Carpenter, Paul A., Gooley, Ted A., Boiko, Julie, Lee, Catherine J., Burroughs, Lauri M., Mehta, Rohtesh, Salit, Rachel B., Bhatt, Neel S., Krakow, Elizabeth, Dahlberg, Ann E., Yeh, Albert C., Summers, Corinne N., Ueda Oshima, Masumi, Petersdorf, Effie W., Vo, Phuong, Connelly-Smith, Laura, Lee, Stephanie J.

    Published in Blood advances (26-11-2024)
    “…•cGVHD declined by ∼19% with each 5-year increment in HCT date even after adjusting for the typically expected cause-associated factors.•cGVHD declines were…”
    Get full text
    Journal Article
  16. 16

    IgG Allotypes Reveal That Antimicrobial Humoral Immunity Persists after Reduced-Intensity Hematopoietic Cell Transplantation by Boiko, Julie R., Sahaf, Bita, Mueller, Antonia M.S., Chen, George L., Tyan, Dolly, Miklos, David B.

    Published in Blood (16-11-2008)
    “…Allogeneic hematopoietic cell transplantation (HCT) is an effective treatment for hematologic malignancies through graft-versus-leukemia/lymphoma (GVL)…”
    Get full text
    Journal Article
  17. 17

    Rituximab Infusion Two Months after HCT Decreases Alloreactive B Cell Responses While Recipient Plasma Cells Persist by Sahaf, Bi ta, Boiko, Julie R., Chen, George, Heydari, Kartoosh, Arai, Sally, Miklos, David

    Published in Blood (16-11-2008)
    “…B cells and their effector molecules, antibodies, are implicated in pathophysiology of the chronic graft-vs-host disease (cGVHD) and rituximab is effective…”
    Get full text
    Journal Article
  18. 18

    Allotype Reagents Distinguish Donor and Recipient Antibodies after Hematopoietic Transplantation by Boiko, Julie R., Sahaf, Bita, Miklos, David B.

    Published in Blood (16-11-2006)
    “…Allogeneic immune responses provide beneficial graft-versus-leukemia (GVL) and detrimental graft-versus-host disease (GVHD). To characterize allogeneic B cells…”
    Get full text
    Journal Article